141 Results

People

  1. O'Reilly
    O'Reilly
  2. Deng
    Deng
  3. Shuman
    Shuman
  4. Dai
    Dai
  5. Sadelain
    Sadelain
  6. Scher
    Scher
  7. Houghton
    Houghton
  8. Merghoub
    Merghoub
  9. Scardino
    Scardino
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. Department of Medicine (141)
  2. Sloan Kettering Institute Faculty (141)
  3. GSK Faculty (106)
  4. Molecular Pharmacology and Chemistry Program Faculty (67)
  5. Hematologic Malignancies, Division of (61)
  6. Center for Hematologic Malignancies (52)
  7. Immunology Program Faculty (50)
  8. Solid Tumor Oncology Division (46)
  9. Division of Subspecialty Medicine (43)
  10. Tow Center for Developmental Oncology (TCDO) (37)
  1. "Department of Medicine"
  2. "Sloan Kettering Institute Faculty"
  3. "Elsevier Science, Inc."
Formats
  1. Meeting Abstract (74)
  2. Journal Article (66)
  3. Review (1)
Groups
  1. Department of Medicine (141)
  2. Sloan Kettering Institute Faculty (141)
  3. GSK Faculty (106)
  4. Molecular Pharmacology and Chemistry Program Faculty (67)
  5. Hematologic Malignancies, Division of (61)
  6. Center for Hematologic Malignancies (52)

More Groups

People
  1. Richard O'Reilly (27)
  2. Liang Deng (24)
  3. Stewart Shuman (23)
  4. Peihong Dai (21)
  5. Michel Sadelain (16)
  6. Howard Scher (12)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Experimental Hematology (46)
  2. Journal of Investigative Dermatology (29)
  3. Journal of the American College of Surgeons (10)
  4. Journal of Urology (9)
  5. Cancer Genetics and Cytogenetics (6)
  6. Biochemical and Biophysical Research Communications (5)

More Publications

Publishers
  1. Elsevier Science, Inc. (141)

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): A phase 3, multicentre, open-label trial
    Journal Article

    Mahadeo, K. M.; Baiocchi, R.; Beitinjaneh, A.; Chaganti, S.; Choquet, S.; Dierickx, D.; Dinavahi, R.; Duan, X.; Gamelin, L.; Ghobadi, A.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Multiome analysis identifies HSC subsets with thymic regenerative capacity
    Meeting Abstract

    Elias, H.; Mitra, S.; da Silva, M.; Gipson, B.; Park, C.; Leslie, C.; Bhandoola, A.; van den Brink, M.
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Validation of a high-sensitivity assay for detection of chimeric antigen receptor T-cell vectors using low-partition digital PCR technology
    Journal Article

    Arcila, M. E.; Patel, U.; Momeni-Boroujeni, A.; Yao, J.; Chan, R.; Chan, J.; Rijo, I.; Yu, W.; Chaves, N.; Patel, H.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: A 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
    Journal Article

    Thakar, M. S.; Logan, B. R.; Puck, J. M.; Dunn, E. A.; Buckley, R. H.; Cowan, M. J.; O'Reilly, R. J.; Kapoor, N.; Satter, L. F.; Pai, S. Y.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Lipid droplets are a metabolic vulnerability in melanoma
    Meeting Abstract

    Lumaquin, D.; Montal, E.; Baggiolini, A.; Ma, Y.; LaPlante, C.; Huang, T.; Suresh, S.; Studer, L.; White, R.
    Journal of Investigative Dermatology (2022)

    Fulltext@MSK | Save
  • Reprogramming the tumor microenvironment by a second-generation recombinant modified vaccinia virus Ankara
    Meeting Abstract

    Liu, S.; Mazo, G.; Yang, N.; Zhang, T.; Tariq, S. B.; Wang, Y.; Hirschhorn-Cymerman, D.; Ji, L.; Tan, A.; Wang, J.; more...
    Journal of Investigative Dermatology (2022)

    Fulltext@MSK | Save
  • Association of family history of cancer with clinical and pathological outcomes for prostate cancer patients on active surveillance
    Journal Article

    Jibara, G. A.; Perera, M.; Vertosick, E. A.; Sjoberg, D. D.; Vickers, A.; Scardino, P. T.; Eastham, J. A.; Laudone, V. P.; Touijer, K.; Lin, X.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Validation of the Memorial Sloan Kettering gastric cancer post-resection survival nomogram: Does it stand the test of time?
    Journal Article

    Nakauchi, M.; Court, C. M.; Tang, L. H.; Gönen, M.; Janjigian, Y. Y.; Maron, S. B.; Molena, D.; Coit, D. G.; Brennan, M. F.; Strong, V. E.
    Journal of the American College of Surgeons (2022)

    Fulltext@MSK | Save
  • The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: A simulation-based analysis
    Journal Article

    Ward, Z. J.; Atun, R.; Hricak, H.; Asante, K.; McGinty, G.; Sutton, E. J.; Norton, L.; Scott, A. M.; Shulman, L. N.
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Development and validation of a disease risk stratification system for patients with haematological malignancies: A retrospective cohort study of the European Society for Blood and Marrow Transplantation registry
    Journal Article

    Shouval, R.; Fein, J. A.; Labopin, M.; Cho, C.; Bazarbachi, A.; Baron, F.; Bug, G.; Ciceri, F.; Corbacioglu, S.; Galimard, J. E.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save